Heiko Golpon

4.9k total citations
67 papers, 3.7k citations indexed

About

Heiko Golpon is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Heiko Golpon has authored 67 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Heiko Golpon's work include Pulmonary Hypertension Research and Treatments (22 papers), Lung Cancer Treatments and Mutations (7 papers) and GDF15 and Related Biomarkers (6 papers). Heiko Golpon is often cited by papers focused on Pulmonary Hypertension Research and Treatments (22 papers), Lung Cancer Treatments and Mutations (7 papers) and GDF15 and Related Biomarkers (6 papers). Heiko Golpon collaborates with scholars based in Germany, United States and Austria. Heiko Golpon's co-authors include Tobias Welte, Marius M. Hoeper, Norbert F. Voelkel, Rubin M. Tuder, Mark W. Geraci, Nils Nickel, Michael E. Yeager, Karen M. Olsson, Mark D. Moore and Volker Westerkamp and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Circulation Research.

In The Last Decade

Heiko Golpon

63 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heiko Golpon Germany 30 2.4k 1.1k 976 486 472 67 3.7k
Alice Huertas France 30 2.4k 1.0× 830 0.7× 814 0.8× 299 0.6× 480 1.0× 66 3.2k
J. Ashley Jefferson United States 27 1.1k 0.5× 382 0.3× 1.6k 1.6× 253 0.5× 673 1.4× 50 5.2k
Florence Duffaud France 42 3.4k 1.4× 593 0.5× 869 0.9× 553 1.1× 1.0k 2.1× 231 5.6k
Joseph P. Miletich United States 37 782 0.3× 1.8k 1.7× 784 0.8× 713 1.5× 1.0k 2.2× 59 7.2k
Christina L. Roland United States 30 1.4k 0.6× 429 0.4× 945 1.0× 585 1.2× 612 1.3× 126 3.6k
Jonathan F. Plehn United States 27 731 0.3× 2.4k 2.2× 617 0.6× 246 0.5× 761 1.6× 61 4.3k
Guowei Che China 30 1.7k 0.7× 436 0.4× 664 0.7× 483 1.0× 1.1k 2.3× 249 3.8k
Kiran Gupta United States 22 666 0.3× 642 0.6× 1.2k 1.2× 377 0.8× 294 0.6× 59 2.9k
Bernd Hohenstein Germany 26 448 0.2× 362 0.3× 1.1k 1.1× 445 0.9× 722 1.5× 87 3.1k
Núria Sala Spain 29 616 0.3× 238 0.2× 575 0.6× 306 0.6× 648 1.4× 97 2.8k

Countries citing papers authored by Heiko Golpon

Since Specialization
Citations

This map shows the geographic impact of Heiko Golpon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heiko Golpon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heiko Golpon more than expected).

Fields of papers citing papers by Heiko Golpon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heiko Golpon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heiko Golpon. The network helps show where Heiko Golpon may publish in the future.

Co-authorship network of co-authors of Heiko Golpon

This figure shows the co-authorship network connecting the top 25 collaborators of Heiko Golpon. A scholar is included among the top collaborators of Heiko Golpon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heiko Golpon. Heiko Golpon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trummer, Arne, Nicolas Dickgreber, Heiko Golpon, et al.. (2022). NSCLC with uncommon EGFR mutations treated with atezolizumab plus bevacizumab and chemotherapy.. Journal of Clinical Oncology. 40(16_suppl). e21076–e21076. 2 indexed citations
2.
Tetzlaff, Fabian, Jelena Epping, Juliane Tetzlaff, Heiko Golpon, & Siegfried Geyer. (2021). Socioeconomic inequalities in lung cancer – a time trend analysis with German health insurance data. BMC Public Health. 21(1). 538–538. 17 indexed citations
3.
Möhn, Nora, Ralf Gutzmer, Imke Satzger, et al.. (2020). Diagnosis and Differential Diagnosis of Neurological Adverse Events during Immune Checkpoint Inhibitor Therapy. Journal of Oncology. 2020. 1–9. 7 indexed citations
4.
Kauffmann‐Guerrero, Diego, Amanda Tufman, Kathrin Kahnert, et al.. (2020). Response to Checkpoint Inhibition in Non-Small Cell Lung Cancer with Molecular Driver Alterations. Oncology Research and Treatment. 43(6). 289–298. 23 indexed citations
5.
Jäger, Benedikt, Denise Klatt, Heiko Golpon, et al.. (2020). CXCR4/MIF axis amplifies tumor growth and epithelial-mesenchymal interaction in non-small cell lung cancer. Cellular Signalling. 73. 109672–109672. 40 indexed citations
6.
Alharbi, Mohammed, Stefan Janssen, Heiko Golpon, Michael Bremer, & Christoph Henkenberens. (2017). Temporal and spatial dose distribution of radiation pneumonitis after concurrent radiochemotherapy in stage III non-small cell cancer patients. Radiation Oncology. 12(1). 165–165. 7 indexed citations
7.
Schmidt, Katharina, Kathrin Damm, Arndt Vogel, et al.. (2017). Therapy preferences of patients with lung and colon cancer: a discrete choice experiment. Patient Preference and Adherence. Volume 11. 1647–1656. 21 indexed citations
8.
Aggarwal, Nupur, Janine Koepke, Nerea Matamala, et al.. (2016). Alpha-1 Antitrypsin Regulates Transcriptional Levels of Serine Proteases in Blood Mononuclear Cells. American Journal of Respiratory and Critical Care Medicine. 193(9). 1065–1067. 4 indexed citations
9.
Jonigk, Danny, Thomas Wolf, Christian Herr, et al.. (2012). Krüppel-like zinc finger proteins in end-stage COPD lungs with and without severe alpha1-antitrypsin deficiency. Orphanet Journal of Rare Diseases. 7(1). 29–29. 11 indexed citations
10.
Zhang, Ruoyu, M. Krüger, Bettina Wiegmann, et al.. (2012). Endobronchial ultrasound guided fine needle aspiration versus transcervical mediastinoscopy in nodal staging of non small cell lung cancer: a prospective comparison study. Journal of Cardiothoracic Surgery. 7(1). 51–51. 16 indexed citations
11.
Jonigk, Danny, Kais Hussein, Lavinia Maegel, et al.. (2011). Obliterative Airway Remodeling. American Journal Of Pathology. 178(2). 599–608. 32 indexed citations
12.
Nickel, Nils, Heiko Golpon, Mark Greer, et al.. (2011). The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension. European Respiratory Journal. 39(3). 589–596. 247 indexed citations
13.
Nickel, Nils, Danny Jonigk, Tibor Kempf, et al.. (2011). GDF-15 is abundantly expressed in plexiform lesions in patients with pulmonary arterial hypertension and affects proliferation and apoptosis of pulmonary endothelial cells. Respiratory Research. 12(1). 62–62. 84 indexed citations
14.
Ghofrani, Hossein Ardeschir, Nicholas W. Morrell, Marius M. Hoeper, et al.. (2010). Imatinib in Pulmonary Arterial Hypertension Patients with Inadequate Response to Established Therapy. American Journal of Respiratory and Critical Care Medicine. 182(9). 1171–1177. 291 indexed citations
15.
Nickel, Nils, Tibor Kempf, Jörn Tongers, et al.. (2008). Growth Differentiation Factor-15 in Idiopathic Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 178(5). 534–541. 113 indexed citations
16.
Hoeper, Marius M., Mathias W. Pletz, Heiko Golpon, & Tobias Welte. (2007). Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension. European Respiratory Journal. 29(5). 944–950. 109 indexed citations
17.
Bühling, Frank, et al.. (2004). Lysosomal cysteine proteases in the lung: role in protein processing and immunoregulation. European Respiratory Journal. 23(4). 620–628. 40 indexed citations
18.
Golpon, Heiko, et al.. (2003). Nitric oxide-dependent vasorelaxation and endothelial cell damage caused by mercury chloride. Toxicology. 192(2-3). 179–188. 21 indexed citations
19.
Tuder, Rubin M., Michael E. Yeager, Mark W. Geraci, Heiko Golpon, & N. F. Voelkel. (2001). Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene. European Respiratory Journal. 17(6). 1065–1069. 27 indexed citations
20.
Golpon, Heiko, et al.. (2001). Vasorelaxant effect of glucagon-like peptide-(7-36)amide and amylin on the pulmonary circulation of the rat. Regulatory Peptides. 102(2-3). 81–86. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alice Huertas Breakdown of academic impact, for papers by J. Ashley Jefferson Breakdown of academic impact, for papers by Florence Duffaud Breakdown of academic impact, for papers by Joseph P. Miletich Breakdown of academic impact, for papers by Christina L. Roland Breakdown of academic impact, for papers by Jonathan F. Plehn Breakdown of academic impact, for papers by Guowei Che Breakdown of academic impact, for papers by Kiran Gupta Breakdown of academic impact, for papers by Bernd Hohenstein Breakdown of academic impact, for papers by Núria Sala
Rankless by CCL
2026